NGF mediates the neuroprotective effect of the β2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study
- 31 July 1999
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 35 (1), 47-57
- https://doi.org/10.1016/s0197-0186(99)00032-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The therapeutic potentials of neurotrophic factors for diseases of the nervous systemExpert Opinion on Therapeutic Patents, 1997
- PHARMACOLOGY OF NEUROTROPHIC FACTORSAnnual Review of Pharmacology and Toxicology, 1997
- Physiology of the NeurotrophinsAnnual Review of Neuroscience, 1996
- Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: Contrasting anatomical and cellular localizationExperimental Neurology, 1995
- Antisense oligonucleotide strategies in neuropharmacologyTrends in Pharmacological Sciences, 1994
- The Potential for Treating Neurodegenerative Disorders with NGF-Inducing CompoundsExperimental Neurology, 1993
- Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctionsNature, 1993
- Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNACell, 1985
- Brain Injury Causes a Time-Dependent Increase in Neuronotrophic Activity at the Lesion SiteScience, 1982
- Focal Cerebral Ischaemia in the Rat: 2. Regional Cerebral Blood Flow Determined by [14C]Iodoantipyrine Autoradiography following Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1981